The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis

Completed · Early Phase 1

Conditions studied: Eosinophilic Esophagitis

In brief

Could Sucralfate be a non-steriodal treatment option for patients with Eosinophilic esophagitis?

Key facts

Study ID

NCT02353078

Run by

Mayo Clinic

People needed

3

Starts

2015-01-01

Expected to finish

2016-12-01

Last updated by the study team

2017-10-11

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients between the ages of 18 and 80 with eosinophilic esophagitis diagnosed by a combination of compatible symptoms, endoscopic findings, histology, and lack of response to proton pump inhibitors.

You may not qualify if…

• Medical conditions such as severe heart or lung disease that preclude safe performance of endoscopy
• Pregnant and lactating females will be excluded
• Diabetic patients will be excluded as episodes of hyperglycemia have been reported
• Patient with chronic renal failure/on dialysis will be excluded
• Patients with conditions known to be associated with esophageal eosinophilia, including Crohn's disease, Churg-Strauss, achalasia, and hypereosinophilic syndrome
• Inability to read due to: Blindness, cognitive dysfunction, or English language illiteracy

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.